secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2026-03-20T23:59:59+00:00
Accession:  0001628280-26-019983
Event type: leadership
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Medifast Enters Cooperation Agreement with Steamboat Capital, Nominates Two Directors, CEO to Step Down June 1, 2026
--------------------------------------------------------------------------------

- Medifast (MED) entered a Cooperation Agreement with Steamboat Capital Partners (beneficial owner >5%) on March 19, 2026.
- Medifast will nominate Steamboat designees Parsa Kiai and Jeff Rose as independent directors at the 2026 annual meeting on May 19, 2026.
- Existing directors Jeffrey Brown and Michael Hoer will not stand for reelection at the 2026 annual meeting.
- CEO Dan Chard will step down on June 1, 2026, remaining Chairman; President Nicholas Johnson to succeed as CEO.
- Steamboat agreed to customary standstill and voting provisions through the 2027 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828026019983/0001628280-26-019983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828026019983/med-20260319.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-019983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer